Related Experiment Video

Updated: Dec 26, 2025

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.2K

When basic science reaches into rational therapeutic design: from historical to novel leads for the treatment of

Charlotte Andrieu-Soler1,2, Eric Soler1,2

  • 1Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier.

Current Opinion in Hematology
|March 14, 2020
PubMed

Insights

Reactivating fetal hemoglobin (HbF) by targeting globin gene expression offers a promising therapeutic strategy for inherited blood disorders like beta-thalassemia and sickle cell disease. Understanding the complex regulatory networks controlling the switch from fetal to adult hemoglobin is key to developing effective treatments.

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Beta-hemoglobinopathies, including beta-thalassemia (β-Thal) and sickle cell disease (SCD), are common inherited blood disorders.
  • These conditions result from defects in adult hemoglobin production, causing anemia and severe complications.
  • Reactivating fetal hemoglobin (HbF) by increasing gamma-globin gene expression is a therapeutic strategy to alleviate disease severity.

Purpose of the Study:

  • To review recent discoveries in the genetic and molecular regulation of the fetal to adult globin gene switch.
  • To discuss novel therapeutic strategies for inducing HbF pharmacologically.
  • To highlight breakthroughs in rational drug design for treating β-Thal and SCD.

Main Methods:

  • Review of recent scientific literature on globin gene regulation.
  • Analysis of molecular and genetic networks controlling the globin switch.
  • Discussion of pharmacological approaches for HbF induction.

Main Results:

  • Identification of novel regulatory factors involved in globin gene expression.
  • Elucidation of complex repression systems maintaining HbF silencing in adults.
  • Emergence of new therapeutic leads based on HbF induction.

Conclusions:

  • Understanding globin gene regulation provides critical insights into treating β-Thal and SCD.
  • Pharmacological induction of HbF represents a significant advancement in managing these inherited blood disorders.
  • These findings pave the way for innovative drug design and improved patient outcomes.
Abstract

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

4.6K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.9K

Related Concept Videos

Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.7K
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
856
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.9K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.2K